Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AMAG Pharmaceuticals Inc (NASDAQ:AMAG)

21.19
BATS BZX Real-Time Price
As of 2:43pm ET
 +0.23 / +1.10%
Today’s Change
17.92
Today|||52-Week Range
77.73
-29.81%
Year-to-Date
Should You Get Rid of AMAG Pharmaceuticals (AMAG) Now?
May 25 / Zacks.com - Paid Partner Content
New Strong Sell Stocks for May 18th
May 18 / Zacks.com - Paid Partner Content
New Strong Sell Stocks for May 19th
May 19 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close20.96
Today’s open21.15
Day’s range20.95 - 21.37
Volume27,736
Average volume (3 months)1,227,017
Market cap$724.8M
Dividend yield--
Data as of 2:43pm ET, 05/31/2016

Growth & Valuation

Earnings growth (last year)-82.73%
Earnings growth (this year)+468.27%
Earnings growth (next 5 years)-2.00%
Revenue growth (last year)+236.28%
P/E ratio59.1
Price/Sales2.55
Price/Book0.78

Competitors

 Today’s
change
Today’s
% change
NTRANatera Inc+0.16+1.19%
VIVOMeridian Bioscience ...+0.01+0.05%
ALRPRBAlere Inc+4.98+1.51%
GHDXGenomic Health Inc-0.16-0.60%
Data as of 2:43pm ET, 05/31/2016

Financials

Next reporting dateJuly 21, 2016
EPS forecast (this quarter)$0.32
Annual revenue (last year)$418.3M
Annual profit (last year)$32.8M
Net profit margin7.84%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Executive Director
William K. Heiden
President &
Chief Operating Officer
Frank E. Thomas
Corporate headquarters
Waltham, Massachusetts

Forecasts

Partner Offers

Search for Jobs